San Marino

San Marino

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.71 (0.59 - 0.84) 2019 Modelled IHME
0.71 (0.59 - 0.83) 2018 Modelled IHME
0.71 (0.58 - 0.83) 2017 Modelled IHME
0.7 (0.57 - 0.81) 2016 Modelled IHME
0.69 (0.56 - 0.81) 2015 Modelled IHME
0.69 (0.57 - 0.81) 2014 Modelled IHME
0.7 (0.57 - 0.82) 2013 Modelled IHME
0.71 (0.58 - 0.83) 2012 Modelled IHME
0.72 (0.59 - 0.84) 2011 Modelled IHME
0.73 (0.59 - 0.86) 2010 Modelled IHME
0.74 (0.60 - 0.87) 2009 Modelled IHME
0.74 (0.60 - 0.88) 2008 Modelled IHME
0.76 (0.60 - 0.89) 2007 Modelled IHME
0.77 (0.60 - 0.91) 2006 Modelled IHME
0.78 (0.61 - 0.92) 2005 Modelled IHME
0.79 (0.61 - 0.93) 2004 Modelled IHME
0.79 (0.63 - 0.93) 2003 Modelled IHME
0.8 (0.64 - 0.94) 2002 Modelled IHME
0.81 (0.65 - 0.95) 2001 Modelled IHME
0.82 (0.66 - 0.97) 2000 Modelled IHME
0.84 (0.67 - 0.98) 1999 Modelled IHME
0.85 (0.68 - 1) 1998 Modelled IHME
0.86 (0.69 - 1.02) 1997 Modelled IHME
0.87 (0.70 - 1.04) 1996 Modelled IHME
0.88 (0.71 - 1.06) 1995 Modelled IHME
0.89 (0.72 - 1.06) 1994 Modelled IHME
0.9 (0.72 - 1.07) 1993 Modelled IHME
0.9 (0.73 - 1.07) 1992 Modelled IHME
0.91 (0.73 - 1.08) 1991 Modelled IHME
0.91 (0.73 - 1.09) 1990 Modelled IHME
0.69 (0.02 - 19.98) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.1 (0.07 - 0.15) 2019 Modelled IHME
0.11 (0.07 - 0.15) 2018 Modelled IHME
0.11 (0.07 - 0.15) 2017 Modelled IHME
0.11 (0.07 - 0.15) 2016 Modelled IHME
0.1 (0.07 - 0.15) 2015 Modelled IHME
0.1 (0.07 - 0.14) 2014 Modelled IHME
0.09 (0.06 - 0.13) 2013 Modelled IHME
0.09 (0.06 - 0.12) 2012 Modelled IHME
0.08 (0.05 - 0.11) 2011 Modelled IHME
0.07 (0.05 - 0.10) 2010 Modelled IHME
0.07 (0.04 - 0.09) 2009 Modelled IHME
0.06 (0.04 - 0.08) 2008 Modelled IHME
0.05 (0.04 - 0.07) 2007 Modelled IHME
0.05 (0.03 - 0.06) 2006 Modelled IHME
0.04 (0.03 - 0.06) 2005 Modelled IHME
0.04 (0.03 - 0.06) 2004 Modelled IHME
0.04 (0.03 - 0.05) 2003 Modelled IHME
0.04 (0.03 - 0.05) 2002 Modelled IHME
0.04 (0.02 - 0.05) 2001 Modelled IHME
0.03 (0.02 - 0.05) 2000 Modelled IHME
0.03 (0.02 - 0.04) 1999 Modelled IHME
0.03 (0.02 - 0.04) 1998 Modelled IHME
0.03 (0.02 - 0.04) 1997 Modelled IHME
0.03 (0.02 - 0.04) 1996 Modelled IHME
0.03 (0.02 - 0.04) 1995 Modelled IHME
0.05 (0.03 - 0.07) 1994 Modelled IHME
0.1 (0.07 - 0.14) 1993 Modelled IHME
0.18 (0.12 - 0.25) 1992 Modelled IHME
0.28 (0.18 - 0.38) 1991 Modelled IHME
0.39 (0.24 - 0.53) 1990 Modelled IHME
0.32 (0.01 - 11.32) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
11 (8 - 16) 2019 Modelled IHME
11 (8 - 16) 2018 Modelled IHME
11 (8 - 16) 2017 Modelled IHME
11 (8 - 16) 2016 Modelled IHME
11 (8 - 16) 2015 Modelled IHME
11 (8 - 16) 2014 Modelled IHME
11 (8 - 16) 2013 Modelled IHME
11 (8 - 16) 2012 Modelled IHME
11 (8 - 16) 2011 Modelled IHME
11 (8 - 16) 2010 Modelled IHME
11 (8 - 16) 2009 Modelled IHME
11 (8 - 16) 2008 Modelled IHME
11 (8 - 16) 2007 Modelled IHME
11 (8 - 16) 2006 Modelled IHME
11 (8 - 16) 2005 Modelled IHME
11 (8 - 16) 2004 Modelled IHME
12 (8 - 17) 2003 Modelled IHME
12 (8 - 17) 2002 Modelled IHME
12 (8 - 18) 2001 Modelled IHME
12 (8 - 18) 2000 Modelled IHME
12 (8 - 18) 1999 Modelled IHME
13 (8 - 18) 1998 Modelled IHME
13 (8 - 18) 1997 Modelled IHME
13 (8 - 18) 1996 Modelled IHME
13 (8 - 18) 1995 Modelled IHME
13 (9 - 19) 1994 Modelled IHME
13 (9 - 19) 1993 Modelled IHME
13 (9 - 19) 1992 Modelled IHME
13 (9 - 19) 1991 Modelled IHME
13 (9 - 19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
78 2018 Survey/reported WHO/UNICEF
82 2017 Survey/reported WHO/UNICEF
86 2016 Survey/reported WHO/UNICEF
84 2015 Survey/reported WHO/UNICEF
83 2014 Survey/reported WHO/UNICEF
83 2013 Survey/reported WHO/UNICEF
88 2012 Survey/reported WHO/UNICEF
92 2011 Survey/reported WHO/UNICEF
89 2010 Survey/reported WHO/UNICEF
89 2009 Survey/reported WHO/UNICEF
91 2008 Survey/reported WHO/UNICEF
91 2007 Survey/reported WHO/UNICEF
92 2006 Survey/reported WHO/UNICEF
95 2005 Survey/reported WHO/UNICEF
95 2004 Survey/reported WHO/UNICEF
96 2003 Survey/reported WHO/UNICEF
96 2002 Survey/reported WHO/UNICEF
96 2001 Survey/reported WHO/UNICEF
97 2000 Survey/reported WHO/UNICEF
97 1999 Survey/reported WHO/UNICEF
97 1998 Survey/reported WHO/UNICEF
97 1997 Survey/reported WHO/UNICEF
98 1996 Survey/reported WHO/UNICEF
98 1995 Survey/reported WHO/UNICEF
98 1994 Survey/reported WHO/UNICEF
98 1993 Survey/reported WHO/UNICEF
99 1992 Survey/reported WHO/UNICEF
99 1991 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.86 (0.70 - 1.04) 2019 Modelled IHME
0.86 (0.71 - 1.05) 2018 Modelled IHME
0.85 (0.70 - 1.05) 2017 Modelled IHME
0.84 (0.69 - 1.03) 2016 Modelled IHME
0.83 (0.67 - 1.01) 2015 Modelled IHME
0.82 (0.68 - 1.01) 2014 Modelled IHME
0.82 (0.68 - 1.01) 2013 Modelled IHME
0.82 (0.67 - 1.01) 2012 Modelled IHME
0.82 (0.67 - 1) 2011 Modelled IHME
0.81 (0.67 - 1) 2010 Modelled IHME
0.81 (0.66 - 1) 2009 Modelled IHME
0.8 (0.66 - 0.99) 2008 Modelled IHME
0.8 (0.65 - 0.98) 2007 Modelled IHME
0.79 (0.65 - 0.97) 2006 Modelled IHME
0.78 (0.64 - 0.96) 2005 Modelled IHME
0.78 (0.64 - 0.96) 2004 Modelled IHME
0.78 (0.64 - 0.95) 2003 Modelled IHME
0.77 (0.64 - 0.95) 2002 Modelled IHME
0.77 (0.63 - 0.94) 2001 Modelled IHME
0.77 (0.63 - 0.94) 2000 Modelled IHME
0.77 (0.63 - 0.94) 1999 Modelled IHME
0.76 (0.62 - 0.94) 1998 Modelled IHME
0.76 (0.62 - 0.94) 1997 Modelled IHME
0.75 (0.62 - 0.93) 1996 Modelled IHME
0.75 (0.62 - 0.92) 1995 Modelled IHME
0.75 (0.61 - 0.92) 1994 Modelled IHME
0.74 (0.61 - 0.93) 1993 Modelled IHME
0.74 (0.61 - 0.92) 1992 Modelled IHME
0.74 (0.60 - 0.91) 1991 Modelled IHME
0.74 (0.60 - 0.92) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
39 (30 - 49) 2019 Modelled IHME
40 (30 - 49) 2018 Modelled IHME
40 (30 - 50) 2017 Modelled IHME
40 (30 - 50) 2016 Modelled IHME
40 (30 - 49) 2015 Modelled IHME
40 (30 - 49) 2014 Modelled IHME
40 (30 - 49) 2013 Modelled IHME
40 (30 - 49) 2012 Modelled IHME
40 (30 - 49) 2011 Modelled IHME
40 (30 - 49) 2010 Modelled IHME
40 (30 - 49) 2009 Modelled IHME
40 (30 - 49) 2008 Modelled IHME
40 (30 - 49) 2007 Modelled IHME
40 (30 - 50) 2006 Modelled IHME
40 (30 - 50) 2005 Modelled IHME
39 (30 - 50) 2004 Modelled IHME
39 (30 - 50) 2003 Modelled IHME
39 (29 - 49) 2002 Modelled IHME
38 (29 - 49) 2001 Modelled IHME
38 (28 - 49) 2000 Modelled IHME
38 (28 - 48) 1999 Modelled IHME
38 (28 - 48) 1998 Modelled IHME
38 (28 - 48) 1997 Modelled IHME
38 (28 - 48) 1996 Modelled IHME
38 (28 - 48) 1995 Modelled IHME
38 (28 - 48) 1994 Modelled IHME
38 (28 - 48) 1993 Modelled IHME
38 (28 - 48) 1992 Modelled IHME
38 (28 - 48) 1991 Modelled IHME
38 (28 - 48) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.71 (%)
2019
(0.59 - 0.84(%))
IHME
HCV (RNA/cAg+)
0.86 (%)
2019
(0.7 - 1.04(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
1
2019
(0 - 1)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
2
2019
(1 - 3)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.10 (%)
2019, latest modelled
(0.07 - 0.15(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines